Press review
Media
Press articles and media passages dealing with cases of meningiomas linked to Androcur, Lutéran, Lotényl, of testimonies and actions in justices of the victims, of scientific publications.
December 21, 2024
News
Media
Help scandal on the progestogen Androcur: Emmanuelle recounts her "trying but essential" fight
November 24, 2024
News
Legal procedures
Media
Androcur: Amavea files a complaint against X for endangering others and aggravated deception
Press contact
Emmanuelle Huet-Mignaton
contact@amavea.org
06 07 58 67 96
The press kit is available for free download.
-
Press review following the announcement by the ANSM of Méningiomes sur-risk with Lotéran and Lotényl on June 17, 2020
Lire la suitePress review following the ANSM's announcement of the increased risk of meningiomas with Lutéran and…
: Revue de Presse suite à l’annonce par l’ANSM du sur-risque de méningiomes avec Lutéran et Lutényl le 17 juin 2020 -
Menopause drugs or endometriosis increase the risk of brain tumor
Lire la suiteMedications for menopause or endometriosis increase the risk of brain tumors. These…
: Des médicaments pour la ménopause ou l’endométriose augmentent le risque de tumeur cérébrale -
Health: used to treat menopause, menstrual disorders and endometriosis, lutenyl and luteran would cause a tumor "over-risk"
Lire la suiteHealth: Used to treat menopause, menstrual disorders, and endometriosis, Lutényl and…
: Santé : utilisés pour traiter la ménopause, les troubles menstruels et l’endométriose, le Lutényl et le Lutéran provoqueraient un « sur-risque » de tumeur -
Risk of confirmed brain tumors for progestogy drugs- Ouest France
Lire la suiteRisk of brain tumors confirmed for progestin drugs - WEST FRANCE Lutéran, Lutényl…
: Risque de tumeurs cérébrales confirmé pour des médicaments progestatifs- OUEST FRANCE
